The Centre has restricted combination cold medicines for young children. Fixed-dose combinations of chlorpheniramine maleate and phenylephrine hydrochloride are now banned. These combinations pose risks and safer alternatives are available for children. Manufacturers must now prominently display warnings on all affected drug labels. This regulatory action follows extensive reviews and recommendations from expert committees.
Read more at the source
Disclaimer: The content of this post is sourced from external sites and is for informational purposes only. All rights and credits belong to the original authors and publishers.